Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell, Peripheral × Epirubicin × Clear all

NCT04061772 2019-08-20

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell, Peripheral